A detailed history of Field & Main Bank transactions in Moderna, Inc. stock. As of the latest transaction made, Field & Main Bank holds 100 shares of MRNA stock, worth $3,685. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$3,685
Previous $11,000 45.45%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022

BUY
$225.82 - $368.51 $22,582 - $36,851
100 New
100 $25,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Field & Main Bank Portfolio

Follow Field & Main Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Field & Main Bank, based on Form 13F filings with the SEC.

News

Stay updated on Field & Main Bank with notifications on news.